Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts General Hospital
M.D. Anderson Cancer Center
Pfizer
University of Wisconsin, Madison
Incyte Corporation
National Cancer Institute (NCI)
Tempus AI
M.D. Anderson Cancer Center
Duke University
Incyte Corporation
Incyte Corporation
Incyte Corporation
Trishula Therapeutics, Inc.
Eli Lilly and Company
University of Washington
Amgen
Bristol-Myers Squibb
NRG Oncology
Spanish Oncology Genito-Urinary Group
Astellas Pharma Inc
University of Washington
Elevation Oncology
Kymab Limited
Indiana University
Incyte Corporation
University of Washington
Daiichi Sankyo
Astellas Pharma Inc
Radiation Therapy Oncology Group
Beth Israel Deaconess Medical Center
Pfizer
M.D. Anderson Cancer Center
Pfizer
Altor BioScience
University of Michigan Rogel Cancer Center
Eli Lilly and Company
NextCure, Inc.
Icahn School of Medicine at Mount Sinai
Tavanta Therapeutics
Processa Pharmaceuticals
Rutgers, The State University of New Jersey
pharmaand GmbH
Columbia University
Fred Hutchinson Cancer Center
Nektar Therapeutics
Nektar Therapeutics
Nektar Therapeutics
Herlev Hospital
Alliance for Clinical Trials in Oncology